DROLEPTAN 2,5 mg/1 ml, solution injectable (IV)

Business Listing - September 04, 2021

DROLEPTAN 2,5 mg/1 ml, solution injectable (IV)

DROLEPTAN 2,5 mg/1 ml, solution injectable (IV) solution injectable intraveineuse Autorisation active Procédure nationale Non commercialisée 9/11/1998 KYOWA KIRIN HOLDINGS (PAYS-BAS)

Tags & Categories

intraveineuse active solution injectable autorisation procédure commercialisée nationale droleptan kyowa

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business